GSK lays off 650 staffers amid closure of German vaccine manufacturing site
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid the pharma’s recent $2.5 billion savings campaign.
Read the full article on the original site.
Read Full Article